MYNZ Mainz Biomed
- 6.680
- +1.910+40.04%
- 6.900
- +0.220+3.29%
Mainz Biomed News
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Quest Diagnostics Deal Sends Mainz Higher
Express News | Mainz Biomed NV - Quest to Provide Lab Services for Mainz Biomed's Reconaasense Study
Express News | Mainz Biomed Forms Agreement With Quest Diagnostics to Provide Clinical Trials Laboratory Services for Colorectal Cancer Screening Test
Mainz Biomed NV Trading Halted, Volatility Trading Pause
Mainz Biomed Prices $8M Offering of Shares and Warrants
Mainz Biomed Offering Expected to Close on or About December 16 >MYNZ
Mainz Biomed: Warrants Will Be Immediately Exercisable at $5.85 Per Share >MYNZ
Mainz Biomed: Each Unit Is Being Sold at $5.85 Apiece >MYNZ
Mainz Biomed Offering 1,367,521 Units, Each Consisting of One Share, One Series a Warrant, One Series B Warrant >MYNZ
Mainz Biomed: Maxim Group LLC Acting as Sole Placement Agent >MYNZ
Mainz Biomed Announces Pricing of $8.0 Million Follow-On Offering Priced At-the-Market
Mainz Biomed N.V. Announces Pricing of Follow-On Offering to Raise Approximately $8.0 Million
Express News | Mainz Biomed NV - Effective Offering Price $5.85 per Unit
Express News | Mainz Biomed Announces Pricing of $8.0 Million Follow-on Offering Priced at-the-Market Under Nasdaq Rules
Express News | Trading Halt: Halt Status Updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption Times
Mainz Biomed NV Trading Halted, News Pending
Express News | Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Mainz Biomed To Carry Out 1-for-40 Reverse Stock Split On December 3rd, 2024
Mainz Biomed Announces 1-For-10 Stock Split; Expected To Begin Trading On The Split-Adjusted Basis At Market Open On December 3, 2024, Upon Nasdaq's Approval
No Data
